P3781
Nonsurgical innovations in the treatment of nonmelanoma skin cancerPEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa studyIngenol mebutate: an introduction.Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response.Ingenol mebutate gel for actinic keratosis.Topical antineoplastic agents in the treatment of mucocutaneous diseases.New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel.An update on nonmelanoma skin cancer.Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens.PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial.The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers.Ivacaftor, vismodegib, and ingenol mebutate.Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches.[What's new in dermato-oncology?].Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosisIngenol mebutate (Picato) for actinic keratosis
P921
Q24632006-6E9CB5D1-2458-4FAD-A7AB-E4BCF8DCFDCDQ28307838-55B5D5DD-D543-4148-9C37-3D4413F9FBD2Q34030817-674A924A-DB04-49E4-8D75-EF374D673618Q34230224-50B645A0-0C3B-470A-A1D5-6C5C07B70F18Q34261250-FDFB253F-6CB0-4378-B834-0736E8EBC83EQ34627002-14E5EAF8-E657-485A-A74E-DE905326FE49Q36196699-79D3CE78-7190-4550-A9E5-224970F66C32Q37851020-9BFBF465-6E2F-4FDD-94C4-E96BFC53FD3DQ38029183-519F7426-CB1A-4F6D-BDA9-23FA10C94930Q42472861-FD1A8B9B-7737-44C0-A2B8-B878DAE65732Q42484803-9610DE3C-4FE0-4466-A391-8BF52F72E3DCQ42506843-2440A61E-0AAB-4BF8-836B-8DBCBC160CE8Q53184438-9FECD084-10E9-4CED-AB14-FFD1D6A83B3FQ54539154-AF5F17C1-7E76-42A4-88D1-6286C5BAE589Q83902342-2C2003F0-6A21-45E2-B78F-44AA6722AB66Q84006026-ACBEBF57-D692-4190-93FB-01F82115A073
P921
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Ingenol Mebutate
@nl
Ingenol mebutat
@sh
Ingenol mebutat
@sr
Ingenol mebutate
@vi
Ingenolmebutat
@de
Ingenolo mebutato
@it
Mebutate ingenol
@es
ingenol mebutate
@en
ingenol-mebutát
@hu
インゲノール 3-アンゲラート
@ja
type
label
Ingenol Mebutate
@nl
Ingenol mebutat
@sh
Ingenol mebutat
@sr
Ingenol mebutate
@vi
Ingenolmebutat
@de
Ingenolo mebutato
@it
Mebutate ingenol
@es
ingenol mebutate
@en
ingenol-mebutát
@hu
インゲノール 3-アンゲラート
@ja
altLabel
3-Angeloylingenol
@de
3-Ingenyl Angelate
@en
Ingenol 3-angelate
@en
Ingenol Mebutate
@en
Ingenol-3-angelat
@de
PEP-005
@en
PEP005
@hu
Picato®
@en
ingenol-3-angelát
@hu
prefLabel
Ingenol Mebutate
@nl
Ingenol mebutat
@sh
Ingenol mebutat
@sr
Ingenol mebutate
@vi
Ingenolmebutat
@de
Ingenolo mebutato
@it
Mebutate ingenol
@es
ingenol mebutate
@en
ingenol-mebutát
@hu
インゲノール 3-アンゲラート
@ja
P129
P2175
P592
P6366
P661
P662
P665
P683
P129
P2017
C/C=C(/C)\C(=O)O[C@H]1C(=C[C@@ ...... [C@H](C4(C)C)C[C@H]3C)CO)O)O)C
P2067
P2115
N0000184493
P2275
Ingenol Mebutate
@en